Elderly women who received Helicobacter pylori-eradicating therapy have reduced risk of low skeletal muscle mass

Myong Ki Baeg, Myung-Gyu Choi, Sun-Hye Ko, Chul-Hyun Lim, Jin Su Kim, Yu Kyung Cho, Jae Myung Park, Young-Seok Cho, Bo-In Lee, In-Seok LeeDepartment of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul, Republic of KoreaBackground: Sarcopenia is associa...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Baeg MK, Choi MG, Ko SH, Lim CH, Kim JS, Cho YK, Park JM, Cho YS, Lee BI, Lee IS
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://doaj.org/article/c9edb032b76540cf8ca81598aa47861d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c9edb032b76540cf8ca81598aa47861d
record_format dspace
spelling oai:doaj.org-article:c9edb032b76540cf8ca81598aa47861d2021-12-02T04:41:51ZElderly women who received Helicobacter pylori-eradicating therapy have reduced risk of low skeletal muscle mass1178-1998https://doaj.org/article/c9edb032b76540cf8ca81598aa47861d2015-10-01T00:00:00Zhttps://www.dovepress.com/elderly-women-who-received-helicobacter-pylori-eradicating-therapy-hav-peer-reviewed-article-CIAhttps://doaj.org/toc/1178-1998Myong Ki Baeg, Myung-Gyu Choi, Sun-Hye Ko, Chul-Hyun Lim, Jin Su Kim, Yu Kyung Cho, Jae Myung Park, Young-Seok Cho, Bo-In Lee, In-Seok LeeDepartment of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul, Republic of KoreaBackground: Sarcopenia is associated with adverse outcomes such as physical disability, poorer quality of life, and death. Helicobacter pylori (HP) eradication increases ghrelin secretion, which may be a possible treatment for sarcopenia. We investigated whether HP eradication reduces the risk of low muscle mass (LMM), which is an integral component of sarcopenia.Materials and methods: Healthy, asymptomatic women aged ≥60 years who participated in a health screening program were enrolled. Subjects with a history of HP eradication were compared with those who were HP IgG+, but had not received HP-eradicating therapy. Body composition was measured by multifrequency bioelectrical impedance analysis. LMM was defined as body muscle mass 2 standard deviations below the mean muscle mass of healthy women aged 20–39 years from the same program. Multivariable analysis was used to identify sarcopenia risk factors.Results: Three hundred seventy-two women had received HP eradication, while 689 HP IgG+ women had not. The prevalence of LMM was significantly lower in those who received HP eradication (13.7% vs 21.6%, P=0.002). Multivariable analysis identified risk factors for LMM as age, white blood cell count, serum total protein concentration, and the metabolic syndrome. HP eradication (odds ratio: 0.632, 95% confidence interval: 0.440–0.824, P=0.013) was a significant preventive factor, and exercise (odds ratio: 0.710, 95% confidence interval: 0.504–1.002, P=0.051) had a preventive tendency.Conclusion: HP eradication might reduce LMM risk. This finding should be confirmed in prospective longitudinal studies to determine the long-term effects of HP eradication on sarcopenia.Keywords: sarcopenia, Helicobacter pylori, eradication, bioelectrical impedance analysisBaeg MKChoi MGKo SHLim CHKim JSCho YKPark JMCho YSLee BILee ISDove Medical PressarticleSarcopeniaHelicobacter pyloriEradicationBioelectrical impedance analysisGeriatricsRC952-954.6ENClinical Interventions in Aging, Vol Volume 10, Pp 1771-1777 (2015)
institution DOAJ
collection DOAJ
language EN
topic Sarcopenia
Helicobacter pylori
Eradication
Bioelectrical impedance analysis
Geriatrics
RC952-954.6
spellingShingle Sarcopenia
Helicobacter pylori
Eradication
Bioelectrical impedance analysis
Geriatrics
RC952-954.6
Baeg MK
Choi MG
Ko SH
Lim CH
Kim JS
Cho YK
Park JM
Cho YS
Lee BI
Lee IS
Elderly women who received Helicobacter pylori-eradicating therapy have reduced risk of low skeletal muscle mass
description Myong Ki Baeg, Myung-Gyu Choi, Sun-Hye Ko, Chul-Hyun Lim, Jin Su Kim, Yu Kyung Cho, Jae Myung Park, Young-Seok Cho, Bo-In Lee, In-Seok LeeDepartment of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul, Republic of KoreaBackground: Sarcopenia is associated with adverse outcomes such as physical disability, poorer quality of life, and death. Helicobacter pylori (HP) eradication increases ghrelin secretion, which may be a possible treatment for sarcopenia. We investigated whether HP eradication reduces the risk of low muscle mass (LMM), which is an integral component of sarcopenia.Materials and methods: Healthy, asymptomatic women aged ≥60 years who participated in a health screening program were enrolled. Subjects with a history of HP eradication were compared with those who were HP IgG+, but had not received HP-eradicating therapy. Body composition was measured by multifrequency bioelectrical impedance analysis. LMM was defined as body muscle mass 2 standard deviations below the mean muscle mass of healthy women aged 20–39 years from the same program. Multivariable analysis was used to identify sarcopenia risk factors.Results: Three hundred seventy-two women had received HP eradication, while 689 HP IgG+ women had not. The prevalence of LMM was significantly lower in those who received HP eradication (13.7% vs 21.6%, P=0.002). Multivariable analysis identified risk factors for LMM as age, white blood cell count, serum total protein concentration, and the metabolic syndrome. HP eradication (odds ratio: 0.632, 95% confidence interval: 0.440–0.824, P=0.013) was a significant preventive factor, and exercise (odds ratio: 0.710, 95% confidence interval: 0.504–1.002, P=0.051) had a preventive tendency.Conclusion: HP eradication might reduce LMM risk. This finding should be confirmed in prospective longitudinal studies to determine the long-term effects of HP eradication on sarcopenia.Keywords: sarcopenia, Helicobacter pylori, eradication, bioelectrical impedance analysis
format article
author Baeg MK
Choi MG
Ko SH
Lim CH
Kim JS
Cho YK
Park JM
Cho YS
Lee BI
Lee IS
author_facet Baeg MK
Choi MG
Ko SH
Lim CH
Kim JS
Cho YK
Park JM
Cho YS
Lee BI
Lee IS
author_sort Baeg MK
title Elderly women who received Helicobacter pylori-eradicating therapy have reduced risk of low skeletal muscle mass
title_short Elderly women who received Helicobacter pylori-eradicating therapy have reduced risk of low skeletal muscle mass
title_full Elderly women who received Helicobacter pylori-eradicating therapy have reduced risk of low skeletal muscle mass
title_fullStr Elderly women who received Helicobacter pylori-eradicating therapy have reduced risk of low skeletal muscle mass
title_full_unstemmed Elderly women who received Helicobacter pylori-eradicating therapy have reduced risk of low skeletal muscle mass
title_sort elderly women who received helicobacter pylori-eradicating therapy have reduced risk of low skeletal muscle mass
publisher Dove Medical Press
publishDate 2015
url https://doaj.org/article/c9edb032b76540cf8ca81598aa47861d
work_keys_str_mv AT baegmk elderlywomenwhoreceivedhelicobacterpylorieradicatingtherapyhavereducedriskoflowskeletalmusclemass
AT choimg elderlywomenwhoreceivedhelicobacterpylorieradicatingtherapyhavereducedriskoflowskeletalmusclemass
AT kosh elderlywomenwhoreceivedhelicobacterpylorieradicatingtherapyhavereducedriskoflowskeletalmusclemass
AT limch elderlywomenwhoreceivedhelicobacterpylorieradicatingtherapyhavereducedriskoflowskeletalmusclemass
AT kimjs elderlywomenwhoreceivedhelicobacterpylorieradicatingtherapyhavereducedriskoflowskeletalmusclemass
AT choyk elderlywomenwhoreceivedhelicobacterpylorieradicatingtherapyhavereducedriskoflowskeletalmusclemass
AT parkjm elderlywomenwhoreceivedhelicobacterpylorieradicatingtherapyhavereducedriskoflowskeletalmusclemass
AT choys elderlywomenwhoreceivedhelicobacterpylorieradicatingtherapyhavereducedriskoflowskeletalmusclemass
AT leebi elderlywomenwhoreceivedhelicobacterpylorieradicatingtherapyhavereducedriskoflowskeletalmusclemass
AT leeis elderlywomenwhoreceivedhelicobacterpylorieradicatingtherapyhavereducedriskoflowskeletalmusclemass
_version_ 1718401150439391232